Global Vascular Closure Devices Market Size Study & Forecast, by Type (Passive Approximators, Active Approximators, External Hemostatic Devices), Access (Femoral, Radial), Procedure (Interventional Cardiology, Interventional Radiology/Vascular Surgery) an

The Global Vascular Closure Devices Market, valued at approximately USD 1.1 billion in 2024, is anticipated to expand at a steady CAGR of 7.00% from 2025 to 2035, reaching an estimated USD 2.32 billion. Vascular closure devices (VCDs) have emerged as pivotal tools in modern interventional procedures, allowing clinicians to rapidly achieve hemostasis after catheterization while minimizing patient discomfort and enabling faster ambulation. Their adoption is increasingly favored over traditional manual compression due to shorter recovery times, reduced vascular complications, and improved patient throughput in hospitals. Growth is being driven by the surge in minimally invasive cardiovascular procedures, rising prevalence of coronary artery disease, and an aging population that presents a higher demand for catheter-based diagnostics and interventions. Additionally, the integration of next-generation biomaterials and resorbable technologies has bolstered clinical outcomes, thereby strengthening market penetration.

The pace of innovation within the vascular closure space is being accelerated by strategic investments from leading medical device companies aiming to enhance device safety, ease of use, and compatibility with smaller sheath sizes. The shift toward radial access, while initially a limiting factor for some femoral-focused closure devices, has spurred the development of radial-specific VCDs, widening the addressable market. According to the American Heart Association, cardiovascular diseases remain the leading cause of mortality globally, underscoring the need for procedural efficiency and complication reduction in interventional cardiology. Moreover, the growing volume of interventional radiology and vascular surgery cases—driven by increased screening and early diagnosis—is further stimulating demand. However, challenges such as high device costs in low-income regions, the need for trained personnel, and occasional device-related complications may temper growth trajectories in certain geographies.

From a geographical perspective, North America commanded the largest market share in 2024, supported by advanced healthcare infrastructure, a high procedural volume of percutaneous interventions, and rapid adoption of innovative closure technologies. The United States, in particular, benefits from strong reimbursement frameworks and a high concentration of key industry players. Europe follows closely, driven by favorable regulatory environments, rising cardiovascular procedure rates, and growing adoption of same-day discharge protocols in cardiac catheterization labs. Meanwhile, Asia Pacific is projected to experience the fastest growth over the forecast period, spurred by expanding healthcare access, increased government investment in cardiac care facilities, and rising incidence of cardiovascular disease in rapidly urbanizing nations such as China and India. The Middle East & Africa, though currently a smaller market, is poised for gradual expansion through healthcare modernization programs and strategic collaborations with international device manufacturers.

Major market player included in this report are:
• Abbott Laboratories
• Terumo Corporation
• Cardinal Health, Inc.
• Teleflex Incorporated
• Boston Scientific Corporation
• Merit Medical Systems, Inc.
• Medtronic plc
• Vasorum Ltd.
• Haemonetics Corporation
• Vivasure Medical Ltd.
• Cardiva Medical, Inc.
• Morris Innovative, Inc.
• TZ Medical, Inc.
• Essential Medical, Inc.
• VasClosure Inc.

Global Vascular Closure Devices Market Report Scope:
• Historical Data – 2023, 2024
• Base Year for Estimation – 2024
• Forecast period – 2025-2035
• Report Coverage – Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Regional Scope – North America; Europe; Asia Pacific; Latin America; Middle East & Africa



The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within the countries involved in the study. The report also provides detailed information about crucial aspects, such as driving factors and challenges, which will define the future growth of the market. Additionally, it incorporates potential opportunities in micro-markets for stakeholders to invest, along with a detailed analysis of the competitive landscape and product offerings of key players.

The detailed segments and sub-segments of the market are explained below:

By Type:
• Passive Approximators
• Active Approximators
• External Hemostatic Devices

By Access:
• Femoral
• Radial

By Procedure:
• Interventional Cardiology
• Interventional Radiology/Vascular Surgery

By Region:

North America
• U.S.
• Canada

Europe
• UK
• Germany
• France
• Spain
• Italy
• Rest of Europe

Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• Rest of Asia Pacific

Latin America
• Brazil
• Mexico

Middle East & Africa
• UAE
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa

Key Takeaways:
• Market Estimates & Forecast for 10 years from 2025 to 2035.
• Annualized revenues and regional level analysis for each market segment.
• Detailed analysis of geographical landscape with Country level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of competitive structure of the market.
• Demand side and supply side analysis of the market.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions. Show more